Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biorepository To Provide Means for Sophisticated Genetic Analysis

By LabMedica International staff writers
Posted on 23 Feb 2009
An extensive biorepository containing a library of samples and information will allow scientists to conduct sophisticated genetic analyses as they explore how age, genetics, and other factors impact a drug's effectiveness.

Aurora Health Care (Milwaukee, WI, USA), nonprofit health care provider will use Tecan's (Männedorf, Switzerland) Freedom EVO liquid handling platforms and REMP small size store to provide automated sample processing, cataloging, and storage for the biorepository. More...
Dr Matt Tector, biorepository director, explained, "The project will rely on surplus blood samples taken for routine clinical tests that would otherwise go to waste. This means patients [will not] have to provide additional blood, so we expect patient consent to be high."

Aurora, which serves a population of more than one million people, and comprises 13 hospitals, over 120 outpatient clinics and approximately 140 pharmacies, is uniquely positioned to create an extensive biorepository. The hospital system expects to collect 100,000 samples a year.

Tecan is a leading global supplier of laboratory instruments and solutions for the diagnostic biopharma, and forensic industries. The company specializes in the development, production, and distribution of automation solutions for life science laboratories. Through its REMP subsidiary, Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include diagnostic laboratories, pharmaceutic and biotech companies, university research departments, and forensics laboratories.

Related Links:

Aurora Health Care
Tecan




New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.